eHealth (EHTH) — Carrier Concentration and Contracting Posture Define Revenue Risk

eHealth operates a consumer-facing private health insurance marketplace and a technology/licensing business that monetizes through commissions, implementation and performance-based licensing fees, and advertising. The company’s economics are driven by large carrier partnerships for Medicare and individual products, with three carriers accounting for a majority of sales in FY2024 and a commercial model that combines agency commissions and recurring technology revenue.

For a closer look at the partner footprint and contract signals that matter to investors, visit https://nullexposure.com/ for ongoing monitoring and context.

Why carrier mix is the primary investment lever

eHealth’s revenue profile is highly concentrated: Humana, UnitedHealthcare and Aetna together represented a meaningful majority of FY2024 revenue, which directly links eHealth’s topline and commission cash flows to the commercial and regulatory behavior of those carriers. That concentration makes carrier contracting posture, regulatory headlines, and the company’s licensing cadence the principal drivers of near-term earnings volatility.

Carrier relationships: every mention from the filings and news

Aetna (10‑K, FY2024)

Aetna represented 18% of eHealth’s total revenue for the year ended December 31, 2024, making it a material revenue contributor in the company’s public accounting of customer concentration. This is noted in eHealth’s 2024 Form 10‑K customer concentration disclosure.

UnitedHealthcare (10‑K, FY2024)

UnitedHealthcare accounted for 22% of total revenue in FY2024, positioning it as the single largest carrier exposure disclosed by eHealth for that year. The company lists this percentage in its FY2024 10‑K customer concentration schedule.

UnitedHealthCare (10‑K, FY2024 entry)

eHealth’s 10‑K also references UnitedHealthCare in a customer concentration context and associated accounts receivable disclosures, reinforcing that payments and receivable timing from this carrier are monitored as a material counterparty exposure in FY2024.

Aetna (news, FierceHealthcare, FY2025)

A March 2026 report by FierceHealthcare relays the DOJ complaint naming Aetna among insurers in a kickback-related allegation that also cites brokers including eHealth; the article reports the DOJ’s claim that brokers received “hundreds of millions” in payments tied to Medicare Advantage enrollments from 2016–2021. This news item elevates regulatory and reputational risk across the broker–carrier ecosystem.

Elevance Health (news, FierceHealthcare, FY2025)

Elevance Health (formerly known as Anthem in public filings) is named in the same FierceHealthcare/DOJ coverage; eHealth appears in the article as one of the brokers identified in the complaint timeframe, which introduces potential indirect legal and compliance exposure associated with carrier-broker interactions.

Humana (news, FierceHealthcare, FY2025)

Humana is likewise named in the March 2026 FierceHealthcare summary of the DOJ complaint; the report cites alleged payments to brokers for steering Medicare Advantage enrollments between 2016 and 2021, which places Humana-related arrangements under regulatory scrutiny in the public reporting period.

Humana (10‑K, FY2024)

Humana accounted for 24% of eHealth’s total revenue for the year ended December 31, 2024, the largest single-carrier share disclosed in the 10‑K, and therefore represents the most concentrated carrier relationship in eHealth’s FY2024 revenue mix.

How operating constraints shape the relationship risk profile

eHealth’s public disclosures and constraint signals outline an operating model with several investor-relevant characteristics:

• Contracting posture — non‑exclusive and short‑term. eHealth states it typically enters non‑exclusive, terminable-on-short-notice agency relationships, implying low switching costs for carriers and an ongoing need to renew or re‑price agreements to protect commissions and licensing income.
• Revenue mix — commissions plus licensing. The company generates revenue through commissions from carrier partners and licensing of its e‑commerce technology, with implementation and performance-based fees tied to application volumes and enrollment outcomes. This hybrid model creates multiple levers for growth but links revenue to carrier product flows and platform adoption.
• Concentration — material single‑counterparty risk. eHealth discloses carriers representing 10%+ of revenue and explicitly lists Humana, UnitedHealthcare and Aetna as material contributors; that structure amplifies earnings sensitivity to any one carrier’s commercial decisions or regulatory problems.
• Counterparty types and geography. eHealth serves both individual consumers and large national carriers, and substantially all revenue is U.S.-based, which focuses geopolitical and regulatory risk domestically but reduces currency or cross-border diversification benefits.
• Relationship maturity and operational role. Many carrier relationships are mature (over ten years) and involve both broker-of-record and BPO/service-provider arrangements under eHealth’s Amplify model, indicating deep operational integration with some partners while contracts remain contractually flexible.
• Segment mix — services-led with software enablers. Most revenue is services and commissions (Medicare and individual segments), with a smaller but strategic licensing/software component that can provide recurring revenue if carriers expand technology programs.

These constraints describe a business that is commercially integrated with a small set of large carriers but contractually exposed to short-term termination and regulatory shifts.

Explore how these signals change over time at https://nullexposure.com/.

Investment implications and risk calendar

• Earnings are carrier‑dependent. With three carriers accounting for the majority of FY2024 revenue, any adverse changes in carrier commission structures, product distribution strategies, or regulatory actions tied to carrier/broker conduct can rapidly compress margins.
• Regulatory headlines are a value driver. The DOJ complaint coverage reported in March 2026 increases the probability of near-term legal and reputational costs across the broker channel; investors should track litigation timelines and any carrier‑specific fallout.
• Upside from licensing and BPO scale. If eHealth expands its technology licensing and BPO contracts, revenue diversification and margin stability would improve; conversely, short‑term, terminable carrier contracts mean this expansion must be sustained through new or renewed agreements.

Conclusion — what investors should watch next

For investors evaluating eHealth, the central questions are whether the company can retain and renegotiate its largest carrier relationships, scale its licensing business, and manage regulatory scrutiny without margin erosion. Monitor quarterly trends in commission mix, any carrier churn disclosures, and legal developments tied to the DOJ coverage. For continual tracking and deeper relationship signals, visit https://nullexposure.com/ for alerts and analytical updates.

Key near-term catalysts: FY2026 quarterly revenue updates, any carrier contract renewals or losses, and outcomes from regulatory inquiries tied to the March 2026 reporting.